GABAA receptor modulator-9
GABAA receptor modulator-9 is and positive allosteric modulator of a1β2y2 subtype GABAA that can cross the blood-brain barrier. GABAA receptor modulator-9 exhibits comparable activity on α1β2γ2 (EC50: 0.9 μM in oocytes, 0.2 μM in CHO cells) and on α1β2, α3β2γ2 and α1β3γ2 (EC50s of 1.3, 3.4 and 1.1 μM). GABAA receptor modulator-9 significantly suppresses seizure progression and reduces delayed mortality. GABAA receptor modulator-9 can be used for the study of status epilepticus (SE).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C23H17N3OS2
- Masse moléculaire:415.53
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
GABAA receptor modulator-9 (Compound (S)-9d) demonstrates the highest selectivity for the α1 subunit, may not exhibit β subunit selectivity and the γ2 subunit does not influence its allosteric activity on GABAARs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Pilocarpine-induced status epilepticus (SE) models established in male C57BL/6N mice (6−8 weeks old, 18-20 g)[1]
-
Dosage:5, 10 and 30 mg/kg
-
Administration:Intraperitoneal injection (i.p.), single dose
-
Result:Exhibited potent therapeutic efficacy, preventing 90% of Stage V seizure onset at 30 mg/kg.
-
Animal Model:Pentylenetetrazole (PTZ)-induced acute convulsive seizures model established in male C57BL/6N mice (6−8 weeks old, 18-20 g)[1]
-
Dosage:5, 10 and 30 mg/kg
-
Administration:Intraperitoneal injection (i.p.), single dose
-
Result:Showed reduced seizure suppression compared to diazepam at equivalent doses during the acute 2 h SE phase at 5 mg/kg.
Achieved 90% prevention of Stage V seizures and significantly delayed the latency to Stage III seizure onset at 30 mg/kg.
Induced mild sedative side effects at doses above 20 mg/kg.
Chemical Information
-
Masse moléculaire 415.53
-
Formule C23H17N3OS2
-
SMILES
O=C1N(C(c2ccccc2)=NC3=C1SC(C4=CC=CS4)=N3)C5=CC=CC=C5CC
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)